跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
THREE-COMPONENT BLOOD-STAGE VACCINE INJECTION AGAINST P.falciparum MALARIA vial - TGA Drug Approval Details
Approvals
/
TGA
/
THREE-COMPONENT BLOOD-STAGE VACCINE INJECTION AGAINST P.falciparum MALARIA vial
Approved
STANDARD
THREE-COMPONENT BLOOD-STAGE VACCINE INJECTION AGAINST P.falciparum MALARIA vial
Saramane Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
eef343cd517b9f62
Company
Saramane Pty Ltd
Type
Standard
Approval Details
Approval Id
eef343cd517b9f62
Product Name
THREE-COMPONENT BLOOD-STAGE VACCINE INJECTION AGAINST P.falciparum MALARIA vial
Artg Id
54540
Artg Name
THREE COMPONENT BLOOD-STAGE VACCINE INJECTION AGAINST P.falciparum MALARIA vial
Sponsor
Saramane Pty Ltd
Artg Date
1996-01-12
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
eef343cd517b9f62
Type
Standard
Back to TGA Approvals